Cite
HARVARD Citation
Harmatz, P. et al. (2017). Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study. American journal of medical genetics. 173 (2), pp. 375-383. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Harmatz, P. et al. (2017). Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study. American journal of medical genetics. 173 (2), pp. 375-383. [Online].